HARDING LOEVNER LP – Neurocrine Biosciences, Inc. Transaction History
HARDING LOEVNER LP portfolio value:
$81,000
portfolio value
HARDING LOEVNER LP quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.31% | -43 shares | 2K | $106.21 | 767 |
| Q2 2022 | share | 0.00% | 0 shares | 18K | $97.48 | 810 | |
| Q1 2022 | share | Increase | +4.25% | 33 shares | -5K | $93.75 | 810 |
| Q4 2021 | share | Increase | +38.26% | 215 shares | 12K | $84.63 | 777 |
| Q3 2021 | share | 0.00% | 0 shares | -1K | $95.91 | 562 | |
| Q2 2021 | share | 0.00% | 0 shares | 0 | $97.32 | 562 | |
| Q1 2021 | share | 0.00% | 0 shares | 1K | $97.25 | 562 | |
| Q4 2020 | share | 0.00% | 0 shares | 0 | $95.85 | 562 | |
| Q3 2020 | share | Increase | +119.53% | 306 shares | 23K | $96.16 | 562 |
| Q2 2020 | share | 0.00% | 0 shares | 9K | $122 | 256 | |
| Q1 2020 | share | Increase | 0.00% | 256 shares | 22K | $86.55 | 256 |